Investors at the Morningstar Investment Conference share which companies they are backing amid the wild market swings.

Other companies, domestic and foreign, have recently warned customers that price hikes related to tariffs are on the way.

Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

The order aims to slash drug prices by up to 80%. Indian industry had been on edge since March amid threats of reciprocal tariff on pharmaceutical products.

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...

President Trump said that prescription benefit managers, or PBMs, would be left out of a new government initiative aimed at ...

The S&P 500 rose for a fourth straight day on Thursday, riding a relief rally in response to the U.S. and China agreeing to ...

President Donald Trump imposed a minimum tariff of 10% on almost all countries, before later suspending the measures ...